Enhanced cutaneous bioavailability of dehydroepiandrosterone mediated by nano-encapsulation.

[1]  R. Guy,et al.  Objective assessment of nanoparticle disposition in mammalian skin after topical exposure. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[2]  R. Renneberg,et al.  Triggering of drug release of particles in hair follicles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Madhu Gupta,et al.  Nanocarrier-based topical drug delivery for the treatment of skin diseases , 2012, Expert opinion on drug delivery.

[4]  Yves Chevalier,et al.  Penetration of drugs through skin, a complex rate-controlling membrane , 2012 .

[5]  R. Kohen,et al.  Skin organ culture as a model to study oxidative stress, inflammation and structural alterations associated with UVB‐induced photodamage , 2011, Experimental dermatology.

[6]  W. Sterry,et al.  Nanoparticles in dermatology , 2011, Archives of Dermatological Research.

[7]  Wolfgang Becker,et al.  Nanoparticles and microparticles for skin drug delivery. , 2011, Advanced drug delivery reviews.

[8]  H. Höltje,et al.  Drug Release and Skin Penetration from Solid Lipid Nanoparticles and a Base Cream: A Systematic Approach from a Comparison of Three Glucocorticoids , 2011, Skin Pharmacology and Physiology.

[9]  B. Bernard,et al.  Skin responses to topical dehydroepiandrosterone: implications in antiageing treatment? , 2010, The British journal of dermatology.

[10]  R. Beck,et al.  Hydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization, and in vitro drug release study , 2010, Drug development and industrial pharmacy.

[11]  H. Fessi,et al.  Development of an original method to study drug release from polymeric nanocapsules in the skin , 2010, The Journal of pharmacy and pharmacology.

[12]  R. Guy,et al.  Disposition of nanoparticles and an associated lipophilic permeant following topical application to the skin. , 2009, Molecular pharmaceutics.

[13]  M. Kampa,et al.  Dehydroepiandrosterone protects human keratinocytes against apoptosis through membrane binding sites. , 2009, Experimental cell research.

[14]  Marc Schneider,et al.  Nanoparticles and their interactions with the dermal barrier , 2009, Dermato-endocrinology.

[15]  S. Hackbarth,et al.  Investigation of Polylactic Acid (PLA) Nanoparticles as Drug Delivery Systems for Local Dermatotherapy , 2009, Pharmaceutical Research.

[16]  D. Duffy,et al.  Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. , 2009, The Journal of investigative dermatology.

[17]  J. Morissette,et al.  Pangenomic changes induced by DHEA in the skin of postmenopausal women , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[18]  O. de Lacharrière,et al.  Effects of topical DHEA on aging skin: a pilot study. , 2008, Maturitas.

[19]  Claus-Michael Lehr,et al.  Nanoparticles--an efficient carrier for drug delivery into the hair follicles. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  Simon Benita,et al.  Targeting of nanoparticles to the clathrin-mediated endocytic pathway. , 2007, Biochemical and biophysical research communications.

[21]  Kwang Hyun Cho,et al.  Modulation of collagen metabolism by the topical application of dehydroepiandrosterone to human skin. , 2005, The Journal of investigative dermatology.

[22]  G. Ceschel,et al.  Solubility and Transdermal Permeation Properties of a Dehydroepiandrosterone Cyclodextrin Complex from Hydrophilic and Lipophilic Vehicles , 2005, Drug delivery.

[23]  E. Touitou,et al.  Testosterone Ethosomes for Enhanced Transdermal Delivery , 2005, Drug delivery.

[24]  Hatem Fessi,et al.  Enhancement of Topical Delivery from Biodegradable Nanoparticles , 2004, Pharmaceutical Research.

[25]  J. Varani,et al.  All-trans retinoic acid improves structure and function of diabetic rat skin in organ culture. , 2002, Diabetes.

[26]  B. W. Barry,et al.  Drug delivery routes in skin: a novel approach. , 2002, Advanced drug delivery reviews.

[27]  J. Heylings,et al.  Comparison of tissue sources for the skin integrity function test (SIFT). , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[28]  J. Bos,et al.  The 500 Dalton rule for the skin penetration of chemical compounds and drugs , 2000, Experimental dermatology.

[29]  E. Baulieu,et al.  Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  V. Meidan,et al.  Methods for quantitative determination of drug localized in the skin. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[31]  M. Caira,et al.  Solid state characterization of dehydroepiandrosterone. , 1995, Journal of pharmaceutical sciences.

[32]  Hatem Fessi,et al.  Nanocapsule formation by interfacial polymer deposition following solvent displacement , 1989 .

[33]  M. Mezei,et al.  Liposomes—A selective drug delivery system for the topical route of administration: gel dosage form , 1982, The Journal of pharmacy and pharmacology.

[34]  S. Pinnell,et al.  Regulation of collagen synthesis by ascorbic acid. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Mezei,et al.  Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form. , 1980, Life sciences.

[36]  B. Baroli,et al.  Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? , 2010, Journal of pharmaceutical sciences.

[37]  S. Legrain,et al.  Pharmacology And Therapeutic Effects of Dehydroepiandrosterone In Older Subjects , 2003, Drugs & aging.

[38]  Raymond C Rowe,et al.  Handbook of Pharmaceutical Excipients , 1994 .

[39]  R. Stoughton.  Penetration of drugs through the skin. , 1976, Dermatologica.